Collaborative-software firm strikes a “strategic business partnership” with major contract manufacturer for supply-chain visibility
Proceeding on a plan announced about a year ago, TraceLink (Woburn, MA) has announced a partnership with Catalent (Somerset, NJ), a leading contract manufacturing organization (CMO) to enable the thousand customers of the latter to look into its manufacturing, inventory and other key performance indicators (KPIs) via an easy-to-use online service from TraceLink called Process Links. The idea is to take data from “the cloud” in much the same manner that social-media sites like Facebook operate and make the data available to trading partners to provide supply-chain visibility.
“This collaboration will add to the already close relationships and excellent communication Catalent shares with its customers,” said Roy Satchell, Catalent’s CIO. “Our customers need strategic partners that can operate seamlessly with them in the execution of supply chain solutions. This collaboration provides that and more—enhancing visibility, improving supply network predictability, and facilitating the incorporation of strategic solutions as part of global supply planning.”
“By using the same application that has a common definition of data, business rules and collaboration tools, we can eliminate the many-to-many, multi-enterprise issues,” writes Shabbir Dahod, TraceLink president, in his company’s blog. “The purpose of a common application is not to supplant current business applications at each company but instead to put into a common application framework the processes we already conduct via our informal activities using fax, phone and email.”
In an interview with Pharmaceutical Commerce, Dahod adds that TraceLink is meant to be an alternative to complex, proprietary communication portals or networks. TraceLink emphasizes a simple “on-ramping” process, and has set its fees at a few hundred dollars per subscriber. Once in the network, trading partners agree between themselves what data to exchange, and what formats to use. Nevertheless, Dahod says that the Catalent partnership has been under way for several months, and that significant development work has been done to “harmonize” data sets.
The partnership should be beneficial on both sides: TraceLink gets a customer with 29 plants worldwide and a thousand customers; and Catalent gets a pioneering IT system that could put it at a competitive advantage to other CMOs. The breadth of Catalent’s operations and customer base will give TraceLink the opportunity to work out many of the KPIs and data flows that typical brand owner/CMO relationships run on. Catalent plans to continuously evolve the collaboration program based on customer feedback, and to launch the program progressively launched throughout its network starting in Q3 2010.
Dahod was the founder of SupplyScape, one of the early developers of pedigree software for documenting movement of pharma products in commercial trade (TraceLink acquired SupplyScape last year, and maintains its pedigree software currently in use). The natural evolution of TraceLink’s technology will be to provide an end-to-end visibility tool from raw material to end customer. Dahod says that TraceLink and Catalent are currently working on extending Catalent’s implementation to its suppliers, and that collaborative networking in commercial trade will be the will continue to be a developmental target. “Next year is 2011,” he notes, adding that preparations for e-pedigree implementations in 2015 are on the rise.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.